企業プロフィール

Better Therapeutics 株価・ニュース・カタリスト

ティッカー:
BTTX
取引所:
NASDAQ
セクター:
Biopharma
所在地:
United States

株価パフォーマンス

0.00 USD (0.00%)

終値

最終更新: 2026年8月17日

時価総額

株価変動の要因

Current closing-price context is not available for BTTX.

企業概要

事業概要

Better Therapeutics was a digital therapeutics company focused on behavior-change software for cardiometabolic disease. The company tried to turn prescription-grade software into a chronic-care treatment option, but its identity was always tied to the difficult economics of digital health.

所在地とセクター分類

Better Therapeutics was headquartered in the United States and listed on NASDAQ. It sat in digital health rather than classic biotechnology, with a product profile centered on software-delivered care.

ビジネスモデルの特徴

The business depended on payer adoption, clinical validation, and the ability to show that software could meaningfully change chronic-disease outcomes. Investors watched commercialization progress, reimbursement, and platform credibility more than clinical trial binaries.

バイオ業界での位置付け

Better Therapeutics occupied a small digital-therapeutics niche within healthcare innovation. Compared with drug developers, its valuation was more sensitive to commercial traction and payer access than to FDA-drug milestones.

今後のカタリスト

  • Better Therapeutics is largely a legacy / closeout story now, so the catalysts are any strategic or asset-resolution update rather than a new product cycle. The market is focused on what remains after the digital-therapy unwind.

最近のニュース

    類似銘柄

    事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。